SCHEMBL893382

SCHEMBL893382

NC(=O)CCCCCCn1c(=O)n(CCCCCCC(N)=O)c(=O)n(CCCCCCC(N)=O)c1=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 4/20 0.38
PTGS2 P35354 4/20 0.38
KDM4E B2RXH2 1/20 0.37
APEX1 P27695 1/20 0.36
MEN1 O00255 1/20 0.36
FAAH O00519 1/20 0.36
TP53 P04637 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2C19 P33261 1/20 0.36
SOAT1 P35610 1/20 0.36
KMT2A Q03164 1/20 0.36
PDE4A P27815 2/20 0.36
PDE4B Q07343 2/20 0.36
PDE4C Q08493 2/20 0.36
PDE4D Q08499 2/20 0.36
PNP P00491 1/20 0.36
FABP4 P15090 1/20 0.35
FABP5 Q01469 1/20 0.35
HDAC1 Q13547 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11721186 0.83 KDM4E (0.50) KDM4EAPEX1PDE4APDE4BPDE4C
SCHEMBL25465029 0.82 PTGS1 (0.57) PTGS1PTGS2APEX1MEN1KMT2A
SCHEMBL25465028 0.79 PTGS1 (0.53) PTGS1PTGS2APEX1MEN1KMT2A
SCHEMBL517606 0.74 KMT2A (0.52) KDM4EMEN1FAAHTP53CYP1A2
SCHEMBL15007818 0.74 KMT2A (0.52) KDM4EMEN1FAAHTP53CYP1A2
SCHEMBL699936 0.74 KMT2A (0.52) KDM4EMEN1FAAHTP53CYP1A2
SCHEMBL25293705 0.74 KMT2A (0.52) KDM4EMEN1FAAHTP53CYP1A2
SCHEMBL25293609 0.74 KMT2A (0.52) KDM4EMEN1FAAHTP53CYP1A2
SCHEMBL42735 0.74 KMT2A (0.52) KDM4EMEN1FAAHTP53CYP1A2
SCHEMBL25288050 0.74 KMT2A (0.52) KDM4EMEN1FAAHTP53CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6586507-B2 For stabilizing polyolefins, especially thermoplastic polyolefins, against the deleterious effects of oxidative, thermal and actinic radiation, also for stabilizing acid catalyzed and ambient cured coatings systems CIBA SPECIALTY CHEMICALS CORPORATION 2003-07-01 US claimed
US-20030120077-A1 Hydroxy substituted N-alkoxy hindered amines and compositions stabilized therewith GALBO JAMES PETER (US) 2003-06-26 US claimed
US-6392041-B1 OXIDATION, HEAT AND RADIATION RESISTANCE CIBA SPECIALTY CHEMICALS CORPORATION 2002-05-21 US claimed
US-20020058735-A1 Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith GALBO JAMES PETER (US) 2002-05-16 US claimed
US-20120083557-A1 STERICALLY HINDERED AMINE STABILIZERS BASF SE (DE) 2012-04-05 US disclosed
US-6872832-B2 Hydroxy substituted N-alkoxy hindered amines and compositions stabilized therewith CIBA SPECIALTY CHEMICALS CORPORATION (US) 2005-03-29 US disclosed
US-6586507-B2 For stabilizing polyolefins, especially thermoplastic polyolefins, against the deleterious effects of oxidative, thermal and actinic radiation, also for stabilizing acid catalyzed and ambient cured coatings systems CIBA SPECIALTY CHEMICALS CORPORATION 2003-07-01 US disclosed
US-20030120077-A1 Hydroxy substituted N-alkoxy hindered amines and compositions stabilized therewith GALBO JAMES PETER (US) 2003-06-26 US disclosed
US-6392041-B1 OXIDATION, HEAT AND RADIATION RESISTANCE CIBA SPECIALTY CHEMICALS CORPORATION 2002-05-21 US disclosed
US-20020058735-A1 Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith GALBO JAMES PETER (US) 2002-05-16 US disclosed
US-6376584-B1 OXIDATION RESISTANCE, HEAT RESISTANCE, PHOTOSTABILITY CIBA SPECIALTY CHEMICALS CORPORATION 2002-04-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120083557-A1 STERICALLY HINDERED AMINE STABILIZERS AAAS, H1-5, H1-2 PTGS1 3600/4885PTGS2 3312/4885KDM4E 456/4885
US-20020058735-A1 Hydroxy-substituted N-alkoxy hindered amines and compositions stabilized therewith OGG1, HAO2, POLH PTGS1 4084/4885PTGS2 3739/4885KDM4E 678/4885
US-20030120077-A1 Hydroxy substituted N-alkoxy hindered amines and compositions stabilized therewith OGG1, POLH, OGFOD1 PTGS1 4291/4885PTGS2 4026/4885KDM4E 679/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.